CN Patent
CN102740842B — 反式降舍曲林的制剂、盐和多晶型物及其应用
Assigned to Sumitomo Pharma America Inc · Expires 2015-07-01 · 11y expired
What this patent protects
本发明提供了包含反式降舍曲林、反式降舍曲林的盐和多晶型形式的药物组合物,制造该组合物的方法,以及应用它们治疗CNS疾病(包括抑郁症)的方法。
USPTO Abstract
本发明提供了包含反式降舍曲林、反式降舍曲林的盐和多晶型形式的药物组合物,制造该组合物的方法,以及应用它们治疗CNS疾病(包括抑郁症)的方法。
Drugs covered by this patent
- Aubagio (TERIFLUNOMIDE) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.